A Phase 2 Study of Temsirolimus (CCI-779) in Patients With Soft Tissue Sarcomas: A Study of the Mayo Phase 2 Consortium (P2C)

BACKGROUND: The primary goal of this trial was to evaluate the confirmed response rate of temsirolimus (CCI-779), a mammalian target of rapamycin in patients with advanced soft tissue sarcomas (STS). METHODS: Patients ≥18 years with measurable advanced STS, no prior chemotherapy for metastatic disea...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Okuno, Scott, Bailey, Howard, Mahoney, Michelle R., Adkins, Douglas, Maples, William, Fitch, Tom, Ettinger, David, Erlichman, Charles, Sarkaria, Jann N.
格式: Artigo
語言:Inglês
出版: 2011
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3312920/
https://ncbi.nlm.nih.gov/pubmed/21287536
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.25928
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍